<DOC>
	<DOCNO>NCT01210976</DOCNO>
	<brief_summary>Patients undergo aortic valve replacement ( AVR ) surgery coronary artery bypass grafting ( CABG ) risk leave ventricular dysfunction . The aim study describe haemodynamic effect levosimendan comparison placebo patient undergo elective aortic valve replacement ( AVR ) together coronary artery bypass grafting ( CABG ) surgery . The study randomize , double-blinded , placebo-controlled carry Heart Center . Twenty four patient randomize two group 12 . The treatment group receive 24 hour infusion levosimendan preoperatively placebo group receive identical infusion thiamine colour glucose . The splanchnic perfusion measure mean vena hepatica cannulation . CircMon B202 ( JR Medical Ltd , Tallinn , Estonia ) use measurement whole-body impedance cardiography derive heart rate , cardiac index , leave cardiac work index , systemic vascular resistance index ( SVRI ) , extracellular water ( ECW ) . Surgical procedure , anaesthesia cardio protection carry standard care . Echo cardiography do pre- postoperatively . Haemodynamics record hourly mixed venous saturation every fourth hour 24 hour .</brief_summary>
	<brief_title>The Effects Levosimendan Haemodynamics Patients Undergoing Elective Aortic Valve Replacement ( AVR ) Together With Coronary Artery Bypass Grafting ( CABG ) Surgery</brief_title>
	<detailed_description />
	<mesh_term>Heart Valve Diseases</mesh_term>
	<mesh_term>Simendan</mesh_term>
	<criteria>LVEF le 50 % leave ventricular hypertrophy indicate wall thickness 12mm allergy levosimendan</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>levosimendan</keyword>
	<keyword>CABG</keyword>
	<keyword>AVR</keyword>
</DOC>